Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers.

Olsen JR, Apisarnthanarax S, Murphy JD, Tait D, Huguet F, Hallemeier CL, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):1-10. doi: 10.1016/j.ijrobp.2019.04.037. Review. No abstract available.

PMID:
31422802
2.

Mismatch Repair System Deficiency is associated with response to neoadjuvant chemoradiation in locally advanced rectal cancer.

Meillan N, Vernerey D, Lefèvre JH, Manceau G, Svrcek M, Augustin J, Fléjou JF, Lascols O, Simon JM, Cohen R, Maingon P, Bachet JB, Huguet F.

Int J Radiat Oncol Biol Phys. 2019 Aug 9. pii: S0360-3016(19)33628-4. doi: 10.1016/j.ijrobp.2019.07.057. [Epub ahead of print]

PMID:
31404579
3.

Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.

Huguet F, Cayuela JM, Cambier N, Carpentier N, Tindel M, Violet I, Zunic P, Lascaux A, Etienne G; AdheRMC Investigators.

Br J Haematol. 2019 Aug 8. doi: 10.1111/bjh.16145. [Epub ahead of print]

PMID:
31394591
4.

Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Etienne G, Dulucq S, Huguet F, Schmitt A, Lascaux A, Hayette S, Fort MP, Sujobert P, Bijou F, Morisset S, Tavitian S, Bidet A, Turcq B, Robbesyn F, Chollet C, Belloc F, Durrieu F, Mahon FX, Nicolini FE.

Cancer Med. 2019 Jul 27. doi: 10.1002/cam4.2410. [Epub ahead of print]

5.

Quality Assurance of Dose Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal Cancer.

Boustani J, Del Campo ER, Blanc J, Peiffert D, Benezery K, Pereira R, Rio E, Le Prisé E, Créhange G, Huguet F.

Int J Radiat Oncol Biol Phys. 2019 Jul 9. pii: S0360-3016(19)33442-X. doi: 10.1016/j.ijrobp.2019.06.2542. [Epub ahead of print]

PMID:
31299242
6.

The Role of Phosphatases in Nuclear Envelope Disassembly and Reassembly and Their Relevance to Pathologies.

Huguet F, Flynn S, Vagnarelli P.

Cells. 2019 Jul 7;8(7). pii: E687. doi: 10.3390/cells8070687. Review.

7.

Outcome of patients aged 60-75 years with newly diagnosed secondary acute myeloid leukemia: A single-institution experience.

Bertoli S, Tavitian S, Bories P, Luquet I, Delabesse E, Comont T, Sarry A, Huguet F, Bérard E, Récher C.

Cancer Med. 2019 Jul;8(8):3846-3854. doi: 10.1002/cam4.2020. Epub 2019 Jun 7.

8.

Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors.

Largeaud L, Bérard E, Bertoli S, Dufrechou S, Prade N, Gadaud N, Tavitian S, Bories P, Luquet I, Sarry A, De Mas V, Huguet F, Delabesse E, Récher C.

Leuk Res. 2019 Jun;81:82-87. doi: 10.1016/j.leukres.2019.04.010. Epub 2019 Apr 27.

PMID:
31055247
9.

Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.

Ta MH, Schernberg A, Giraud P, Monnier L, Darai É, Bendifallah S, Schlienger M, Touboul E, Orthuon A, Challand T, Huguet F, Rivin Del Campo E.

Acta Oncol. 2019 Aug;58(8):1127-1134. doi: 10.1080/0284186X.2019.1599136. Epub 2019 Apr 24.

PMID:
31017032
10.

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers.

Giraud P, Giraud P, Gasnier A, El Ayachy R, Kreps S, Foy JP, Durdux C, Huguet F, Burgun A, Bibault JE.

Front Oncol. 2019 Mar 27;9:174. doi: 10.3389/fonc.2019.00174. eCollection 2019. Review.

11.

Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers.

Hallemeier CL, Olsen JR, Murphy JD, Tait D, Apisarnthanarax S, Huguet F, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):1-9. doi: 10.1016/j.ijrobp.2018.12.052. No abstract available.

PMID:
30967220
12.

[Effects of high-dose irradiation on vascularization: Physiopathology and clinical consequences].

Nivet A, Schlienger M, Clavère P, Huguet F.

Cancer Radiother. 2019 Apr;23(2):161-167. doi: 10.1016/j.canrad.2018.05.009. Epub 2019 Mar 25. Review. French.

PMID:
30922894
13.

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.

Touzart A, Lengliné E, Latiri M, Belhocine M, Smith C, Thomas X, Spicuglia S, Puthier D, Pflumio F, Leguay T, Graux C, Chalandon Y, Huguet F, Leprêtre S, Ifrah N, Dombret H, Macintyre E, Hunault M, Boissel N, Asnafi V.

Clin Cancer Res. 2019 Apr 15;25(8):2483-2493. doi: 10.1158/1078-0432.CCR-18-1844. Epub 2019 Jan 18.

PMID:
30659025
14.

DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.

Bond J, Touzart A, Leprêtre S, Graux C, Bargetzi M, Lhermitte L, Hypolite G, Leguay T, Hicheri Y, Guillerm G, Bilger K, Lhéritier V, Hunault M, Huguet F, Chalandon Y, Ifrah N, Macintyre E, Dombret H, Asnafi V, Boissel N.

Haematologica. 2019 Aug;104(8):1617-1625. doi: 10.3324/haematol.2018.197848. Epub 2019 Jan 17.

15.

[Chemoradiation for oesophageal cancer: A critical review of the literature].

Blais E, Vendrely V, Sargos P, Créhange G, Huguet F, Maingon P, Simon JM, Bourdais R, Ozsahin M, Bourhis J, Clément-Colmou K, Belghith B, Proudhom Briois MA, Gilliot O, Dujols JP, Peyras A, Dupin C, Riet FG, Canova CH, Huertas A, Troussier I.

Cancer Radiother. 2019 Feb;23(1):62-72. doi: 10.1016/j.canrad.2018.05.003. Epub 2019 Jan 11. Review. French.

PMID:
30639379
16.

The impact of chronic myeloid leukemia on employment: the French prospective study.

De Barros S, Vayr F, Despas F, Strumia M, Podevin C, Gauthier M, Delabesse E, Soulat JM, Laurent G, Huguet F, Herin F.

Ann Hematol. 2019 Mar;98(3):615-623. doi: 10.1007/s00277-018-3549-5. Epub 2018 Nov 17.

PMID:
30446803
17.

Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis.

Bertoli S, Tavitian S, Picard M, Huguet F, Vergez F, Delabesse E, Sarry A, Bérard E, Récher C.

Leuk Res. 2018 Dec;75:7-10. doi: 10.1016/j.leukres.2018.10.015. Epub 2018 Oct 31. No abstract available.

PMID:
30419550
18.

How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort.

Pietrasz D, Turrini O, Vendrely V, Simon JM, Hentic O, Coriat R, Portales F, Le Roy B, Taieb J, Regenet N, Goere D, Artru P, Vaillant JC, Huguet F, Laurent C, Sauvanet A, Delpero JR, Bachet JB, Sa Cunha A.

Ann Surg Oncol. 2019 Jan;26(1):109-117. doi: 10.1245/s10434-018-6931-6. Epub 2018 Oct 25.

PMID:
30362063
19.

[Siriade 2.0: An e-learning platform for radiation oncology contouring].

Bibault JE, Denis F, Roué A, Gibon D, Fumagalli I, Hennequin C, Barillot I, Quéro L, Paumier A, Mahé MA, Servagi Vernat S, Créhange G, Lapeyre M, Blanchard P, Pointreau Y, Lafond C, Huguet F, Mornex F, Latorzeff I, de Crevoisier R, Martin V, Kreps S, Durdux C, Antoni D, Noël G, Giraud P.

Cancer Radiother. 2018 Dec;22(8):773-777. doi: 10.1016/j.canrad.2018.02.003. Epub 2018 Oct 22. French.

PMID:
30360973
20.

Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.

Bertoli S, Paubelle E, Bérard E, Saland E, Thomas X, Tavitian S, Larcher MV, Vergez F, Delabesse E, Sarry A, Huguet F, Larrue C, Bosc C, Farge T, Sarry JE, Michallet M, Récher C.

Eur J Haematol. 2019 Feb;102(2):131-142. doi: 10.1111/ejh.13183. Epub 2018 Nov 28.

PMID:
30325535
21.

Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC).

Neuzillet C, Gaujoux S, Williet N, Bachet JB, Bauguion L, Colson Durand L, Conroy T, Dahan L, Gilabert M, Huguet F, Marthey L, Meilleroux J, de Mestier L, Napoléon B, Portales F, Sa Cunha A, Schwarz L, Taieb J, Chibaudel B, Bouché O, Hammel P; Thésaurus National de Cancérologie Digestive (TNCD); Société Nationale Française de Gastroentérologie (SNFGE); Fédération Francophone de Cancérologie Digestive (FFCD); Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR); Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER); Société Française de Chirurgie Digestive (SFCD); Société Française d’Endoscopie Digestive (SFED); Société Française de Radiothérapie Oncologique (SFRO); Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation (ACHBT); Association Française de Chirurgie (AFC).

Dig Liver Dis. 2018 Dec;50(12):1257-1271. doi: 10.1016/j.dld.2018.08.008. Epub 2018 Aug 18. Review.

PMID:
30219670
22.

Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group.

Bendifallah S, de Foucher T, Ouldamer L, Bricou A, Lavoue V, Varinot J, Canlorbe G, Carcopino X, Raimond E, Huguet F, Graesslin O, Touboul C, Collinet P, Huchon C, Daraï E, Ballester M; Groupe de Recherche FRANCOGYN.

Eur J Surg Oncol. 2018 Dec;44(12):1921-1928. doi: 10.1016/j.ejso.2018.08.013. Epub 2018 Aug 30.

PMID:
30213717
23.

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study.

Heiblig M, Rea D, Chrétien ML, Charbonnier A, Rousselot P, Coiteux V, Escoffre-Barbe M, Dubruille V, Huguet F, Cayssials E, Hermet E, Guerci-Bresler A, Amé S, Sackmann-Sala L, Roy L, Sobh M, Morisset S, Etienne G, Nicolini FE.

Exp Hematol. 2018 Nov;67:41-48. doi: 10.1016/j.exphem.2018.08.006. Epub 2018 Sep 5.

PMID:
30195076
24.

Gastrointestinal Cancers-Carving Out the Optimal Local Therapies in the Gastrointestinal Tract.

Olsen JR, Murphy JD, Huguet F, Hallemeier CL, Apisarnthanarax S, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):233-242. doi: 10.1016/j.ijrobp.2018.05.026. No abstract available. Erratum in: Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):286.

PMID:
30191854
25.

[Rectal cancer radiotherapy: Therapeutical strategy and perspective].

Vendrely V, Denost Q, Charleux T, Brouquet A, Huguet F, Rullier E.

Cancer Radiother. 2018 Oct;22(6-7):558-563. doi: 10.1016/j.canrad.2018.06.004. Epub 2018 Aug 28. Review. French.

PMID:
30170787
26.

[Role of radiation therapy in the management of pancreatic cancer].

Huguet F, Rivin Del Campo E, Antoni D, Vendrely V, Hammel P.

Cancer Radiother. 2018 Oct;22(6-7):552-557. doi: 10.1016/j.canrad.2018.06.005. Epub 2018 Aug 9. Review. French.

PMID:
30100126
27.

GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer.

Jabbour SK, Apisarnthanarax S, Hallemeier CL, Huguet F, Murphy JD, Olsen JR.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):749-758. doi: 10.1016/j.ijrobp.2017.11.031. Epub 2018 Jun 20. No abstract available.

PMID:
29976479
28.

Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database.

Olsen JR, Murphy JD, Hallemeier CL, Apisarnthanarax S, Huguet F, Jabbour SK.

J Clin Oncol. 2018 Aug 20;36(24):2564-2565. doi: 10.1200/JCO.2018.78.2904. Epub 2018 Jun 26. No abstract available.

PMID:
29945521
29.

Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives.

Schernberg A, Rivin Del Campo E, Rousseau B, Matzinger O, Loi M, Maingon P, Huguet F.

Clin Transl Radiat Oncol. 2018 Mar 13;10:13-22. doi: 10.1016/j.ctro.2018.02.005. eCollection 2018 Mar. Review.

30.

Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies.

Bertoli S, Tavitian S, Berard E, Gadaud N, Luquet I, Huynh A, Sarry A, Huguet F, Récher C.

Leuk Lymphoma. 2019 Jan;60(1):238-241. doi: 10.1080/10428194.2018.1464156. Epub 2018 Jun 12. No abstract available.

PMID:
29893611
31.

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.

Huguet F, Chevret S, Leguay T, Thomas X, Boissel N, Escoffre-Barbe M, Chevallier P, Hunault M, Vey N, Bonmati C, Lepretre S, Marolleau JP, Pabst T, Rousselot P, Buzyn A, Cahn JY, Lhéritier V, Béné MC, Asnafi V, Delabesse E, Macintyre E, Chalandon Y, Ifrah N, Dombret H; Group of Research on Adult ALL (GRAALL).

J Clin Oncol. 2018 Aug 20;36(24):2514-2523. doi: 10.1200/JCO.2017.76.8192. Epub 2018 Jun 4.

32.

Monitoring of asparagine depletion and anti-L-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial.

Paillassa J, Leguay T, Thomas X, Huguet F, Audrain M, Lheritier V, Vianey-Saban C, Acquaviva-Bourdain C, Pagan C, Dombret H, Ifrah N, Boissel N, Hunault-Berger M.

Blood Cancer J. 2018 May 22;8(5):45. doi: 10.1038/s41408-018-0084-5. No abstract available.

33.

Dexamethasone in hyperleukocytic acute myeloid leukemia.

Bertoli S, Picard M, Bérard E, Griessinger E, Larrue C, Mouchel PL, Vergez F, Tavitian S, Yon E, Ruiz J, Delabesse E, Luquet I, Linares LK, Saland E, Carroll M, Danet-Desnoyers G, Sarry A, Huguet F, Sarry JE, Récher C.

Haematologica. 2018 Jun;103(6):988-998. doi: 10.3324/haematol.2017.184267. Epub 2018 Mar 8.

34.

Improved outcome for AML patients over the years 2000-2014.

Bertoli S, Tavitian S, Huynh A, Borel C, Guenounou S, Luquet I, Delabesse E, Sarry A, Laurent G, Attal M, Huguet F, Bérard E, Récher C.

Blood Cancer J. 2017 Nov 29;7(12):635. doi: 10.1038/s41408-017-0011-1.

35.

Buserelin alleviates chloride transport defect in human cystic fibrosis nasal epithelial cells.

Calvez ML, Benz N, Huguet F, Saint-Pierre A, Rouillé E, Coraux C, Férec C, Kerbiriou M, Trouvé P.

PLoS One. 2017 Nov 16;12(11):e0187774. doi: 10.1371/journal.pone.0187774. eCollection 2017.

36.

Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia.

Dumas PY, Bertoli S, Bérard E, Médiavilla C, Yon E, Tavitian S, Leguay T, Huguet F, Forcade E, Milpied N, Sarry A, Sauvezie M, Bories P, Pigneux A, Récher C.

Oncotarget. 2017 Mar 7;8(45):79126-79136. doi: 10.18632/oncotarget.15988. eCollection 2017 Oct 3.

37.

Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy.

Comont T, Tavitian S, Bardiaux L, Fort M, Debiol B, Morère D, Bérard E, Delabesse E, Luquet I, Martinez S, Huguet F, Récher C, Bertoli S.

Leuk Res. 2017 Oct;61:62-67. doi: 10.1016/j.leukres.2017.08.015. Epub 2017 Aug 30.

PMID:
28910610
38.

[Clinical research for rectal carcinoma: State of the art and objectives].

Maingon P, Simon JM, Canova CH, Troussier I, Besson N, Caillot É, Huguet F.

Cancer Radiother. 2017 Oct;21(6-7):533-535. doi: 10.1016/j.canrad.2017.07.019. Epub 2017 Sep 7. French.

PMID:
28890092
39.

Chemoradiation for Unresectable Pancreatic Cancer Can Improve Quality of Life and Does Not Exclude Potential Resection.

Huguet F, Vendrely V.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):299-300. doi: 10.1016/j.ijrobp.2017.05.032. No abstract available.

PMID:
28871976
40.

[Role of induction chemotherapy in head and neck cancer: Cons].

Huguet F, Schick U, Pointreau Y.

Cancer Radiother. 2017 Oct;21(6-7):510-514. doi: 10.1016/j.canrad.2017.07.020. French.

PMID:
28869196
41.

[How to manage a rectal cancer with synchronous liver metastases? A question of strategy].

Vendrely V, Terlizzi M, Huguet F, Denost Q, Chiche L, Smith D, Bachet JB.

Cancer Radiother. 2017 Oct;21(6-7):539-543. doi: 10.1016/j.canrad.2017.07.021. Epub 2017 Aug 30. Review. French.

PMID:
28869194
42.

[Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)].

Biau J, Miroir J, Millardet C, Saroul N, Pham-Dang N, Racadot S, Huguet F, Kwiatkowski F, Pereira B, Bourhis J, Lapeyre M.

Cancer Radiother. 2017 Oct;21(6-7):527-532. doi: 10.1016/j.canrad.2017.07.033. Epub 2017 Aug 31. French.

PMID:
28865970
43.

[Role and interest of induction chemotherapy for head and neck cancers].

Pointreau Y, Schick U, Huguet F.

Cancer Radiother. 2017 Oct;21(6-7):505-509. doi: 10.1016/j.canrad.2017.07.034. Epub 2017 Aug 31. French.

PMID:
28865969
44.

[Radiotherapy for head and neck squamous cell carcinoma: State of the art and future directions].

Schick U, Huguet F, Pointreau Y, Pradier O.

Cancer Radiother. 2017 Oct;21(6-7):498-504. doi: 10.1016/j.canrad.2017.07.032. Epub 2017 Aug 31. Review. French.

PMID:
28864046
45.

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.

Lafage-Pochitaloff M, Baranger L, Hunault M, Cuccuini W, Lefebvre C, Bidet A, Tigaud I, Eclache V, Delabesse E, Bilhou-Nabéra C, Terré C, Chapiro E, Gachard N, Mozziconacci MJ, Ameye G, Porter S, Grardel N, Béné MC, Chalandon Y, Graux C, Huguet F, Lhéritier V, Ifrah N, Dombret H; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL).

Blood. 2017 Oct 19;130(16):1832-1844. doi: 10.1182/blood-2017-05-783852. Epub 2017 Aug 8.

46.

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.

Legros L, Nicolini FE, Etienne G, Rousselot P, Rea D, Giraudier S, Guerci-Bresler A, Huguet F, Gardembas M, Escoffre M, Ianotto JC, Noël MP, Varet BR, Pagliardini T, Touitou I, Morisset S, Mahon FX; French Intergroup for Chronic Myeloid Leukemias.

Cancer. 2017 Nov 15;123(22):4403-4410. doi: 10.1002/cncr.30885. Epub 2017 Jul 25.

47.

External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.

Schernberg A, Huguet F, Moureau-Zabotto L, Chargari C, Rivin Del Campo E, Schlienger M, Escande A, Touboul E, Deutsch E.

Radiother Oncol. 2017 Jul;124(1):110-117. doi: 10.1016/j.radonc.2017.06.009. Epub 2017 Jun 26.

PMID:
28662871
48.

Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.

Bétrian S, Guenounou S, Luquet I, Demur C, Huynh A, Ysebaert L, Recher C, Huguet F.

Hematol Oncol. 2017 Jun;35(2):252-255. doi: 10.1002/hon.2252. Epub 2015 Oct 8.

PMID:
28620927
49.

Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).

Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, Huguet F, Peiffert D, Siproudhis L, Ducreux M, Bouché O.

Dig Liver Dis. 2017 Aug;49(8):831-840. doi: 10.1016/j.dld.2017.05.011. Epub 2017 May 23. Review.

PMID:
28610905
50.

Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.

Bond J, Graux C, Lhermitte L, Lara D, Cluzeau T, Leguay T, Cieslak A, Trinquand A, Pastoret C, Belhocine M, Spicuglia S, Lheritier V, Leprêtre S, Thomas X, Huguet F, Ifrah N, Dombret H, Macintyre E, Boissel N, Asnafi V.

J Clin Oncol. 2017 Aug 10;35(23):2683-2691. doi: 10.1200/JCO.2016.71.8585. Epub 2017 Jun 12.

PMID:
28605290

Supplemental Content

Loading ...
Support Center